Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥436.6bn2023-04-01 → 2023-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥228.9bn2023-07-01 → 2023-09-30dCons.Revenue IFRS (5-year summary)
Revenue¥881.9bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥417.1bn2022-04-01 → 2022-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥224.8bn2022-07-01 → 2022-09-30dCons.Revenue IFRS (5-year summary)
Operating income¥4.8bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income−¥17.7bn2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income¥93.6bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥49.1bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax−¥958m2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥20.7bn2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax¥182.3bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥89.3bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥47.3bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥216.3bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥24.3bn2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥143.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥66.8bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥216.7bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Net income−¥24.0bn2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income¥66.9bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥1.62Tat 2023-09-30Cons.Assets IFRS
Total assets¥1.51Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.49Tat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥790.2bnat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥867.1bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥827.5bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥641.2bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥644.1bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥511.4bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥827.5bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥640.1bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥643.0bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥488.2bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥169.3bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥297.4bnat 2022-09-30Cons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow−¥11.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥98.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥6.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥412.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥58.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥15.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥125.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥143.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥35.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥173.812023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-19.642023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥113.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥52.52022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.972022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥173.432023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-19.62023-07-01 → 2023-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥113.082022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥52.452022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥32.932022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio51.2%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio42.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.3%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥18.6bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2023-04-01 → 2023-09-30¥50.9bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2023-04-01 → 2023-09-30−¥28.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥23.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥4.3bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥68.9bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2022-04-01 → 2022-09-30−¥788m
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥29.8bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥97.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 781
ItemContextValueUnit
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration-JPY
Share based payment transactions ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember453000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember1231000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember1684000000JPY
Share based payment transactions ss IFRSCurrentYTDDuration1684000000JPY
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-1592000000JPY
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-1592000000JPY
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-1329000000JPY
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration-2921000000JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareCapitalIFRSMember-JPY
Total transactions with owners IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-1113000000JPY
Total transactions with owners IFRSCurrentYTDDuration_TreasurySharesIFRSMember-62722000000JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember261000000JPY
Total transactions with owners IFRSCurrentYTDDuration_jpcrp040300-q2r_E02272-000OtherComponentsOfCapitalRelatedToTheDisposalGroupHeldForSaleIFRSMember-JPY
Total transactions with owners IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-20367000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-83941000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-1512000000JPY
Total transactions with owners IFRSCurrentYTDDuration-85453000000JPY
Equity IFRSCurrentQuarterInstant_ShareCapitalIFRSMember124643000000JPY
Equity IFRSCurrentQuarterInstant_CapitalSurplusIFRSMember91037000000JPY
Equity IFRSCurrentQuarterInstant_TreasurySharesIFRSMember-90808000000JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember135667000000JPY
Equity IFRSCurrentQuarterInstant_jpcrp040300-q2r_E02272-000OtherComponentsOfCapitalRelatedToTheDisposalGroupHeldForSaleIFRSMember-JPY
Equity IFRSCurrentQuarterInstant_RetainedEarningsIFRSMember566993000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember827532000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember-JPY
Equity IFRSCurrentQuarterInstant827532000000JPY
Profit loss before tax IFRSPrior1YTDDuration89321000000JPY
Profit loss before tax IFRSCurrentYTDDuration-958000000JPY
Profit loss before tax from discontinued operations IFRSPrior1YTDDuration-3973000000JPY
Profit loss before tax from discontinued operations IFRSCurrentYTDDuration348182000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration35818000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration32894000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration732000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration41739000000JPY
Interest and dividend income ope cf IFRSPrior1YTDDuration-1508000000JPY
Interest and dividend income ope cf IFRSCurrentYTDDuration-1130000000JPY
Interest expenses ope cf IFRSPrior1YTDDuration2993000000JPY
Interest expenses ope cf IFRSCurrentYTDDuration2795000000JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSPrior1YTDDuration-15769000000JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSCurrentYTDDuration71000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration-371000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration234000000JPY
Gain on transfer of ssd ope cf IFRSPrior1YTDDuration-JPY
Gain on transfer of ssd ope cf IFRSCurrentYTDDuration-349036000000JPY
Decrease increase in trade and other receivables ope cf IFRSPrior1YTDDuration3168000000JPY
Decrease increase in trade and other receivables ope cf IFRSCurrentYTDDuration12405000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration-20066000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-14371000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass